Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
Molecular Therapy2012Vol. 20(9), pp. 1689–1698
Citations Over TimeTop 10% of 2012 papers
Omar D. Perez, Christopher R. Logg, Kei Hiraoka, Oscar R. Diago, Ryan Burnett, Akihito Inagaki, Dawn Jolson, Karin Amundson, Taylor Buckley, Dan Lohse, Amy Lin, Cindy Burrascano, Carlos E. Ibañez, Noriyuki Kasahara, Harry E. Gruber, Douglas J. Jolly
Related Papers
- → Cytotoxic effect of the cytosine deaminase gene delivered by the adenovirus vector in murine gastric cancer(2001)1 cited
- [Anticancer efficacy of combining cytosine deaminase/5-fluorocytosine gene therapy and radiotherapy on cervical carcinoma].(2005)
- [Improvements of lentiviral vector and its application in gene therapy of hematological diseases].(2003)
- The progress of retroviral vector in hemophilia A gene therapy(2001)
- → 501. Porcine Adenoviral Vectors as Promising Supplement to Human Adenoviral Vectors for Gene Therapy(2003)